Chinese Society of Toxicology
Dr. Li-jie Fu is a Distinguished Research Fellow and Vice President of Shanghai InnoStar Bio-tech (National Shanghai Center for New Drug Safety Evaluation & Research , NCDSER). He is a Fellow of Academy of Toxicological Science (ATS) and has been active in toxicology for more than thirty (30) years. He had served as Regulatory Advisor for Shin Nippon Biomedical Laboratories, Ltd. (SNBL), and as Executive Vice President at Medicilon/MPI Pre-Clinical Research, Vice President of Operations at WuXi Apptech Co., Ltd. Prior to joining WuXi, Dr. Fu was a Vice President of Global Integration of Bridge Pharmaceuticals, and President/CEO of Next Century Incorporated. Dr. Fu currently serves as Vice President & Secretary General of the Chinese Society of Toxicology, President-elect of Asian Society of Toxicology, a member of IUTOX Executive Committee and Co-Chair of Education Committee and Chair of Toxicology Recognition (TRTF). He has published several four books in Chinese where he was First Author/Chief Editor, authored over seventy (70) articles and many book chapters in Chinese and in English.